NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM4989813 Query DataSets for GSM4989813
Status Public on Dec 28, 2020
Title Subject ID: IN.GN.527_IgA
Sample type protein
 
Source name human breast milk
Organism Homo sapiens
Characteristics region: Ghana
mother's age: 37
infant's sex: 1
time post-partum: 48
parity: 2
delivery: Vaginal
bmi: 27.7
bmi code: OVERWEIGHT
mother's height (cm): 160.1
companion animals: NO
agricultural animals: NO
adjusted household density: 2
molecule type: IgA
Extracted molecule protein
Extraction protocol Sampling protocol: In PE, SW, USC, and USW, milk was collected using an electric breast pump. In all other cohorts, milk was manually expressed. Except for those collected in ETR, samples were immediately placed on ice, aliquoted within 30 min, and frozen at −20°C. Milk collected in ETR was preserved in a 1:1 ratio with Milk Preservation Solution (Norgen Biotek, Cat. 44800, Thorold, Ontario) and frozen within 6 d. We have shown previously that this method can maintain bacterial DNA integrity in human milk held at 37°C for at least 2 wk (34). All samples were shipped on dry ice to the University of Idaho, where they were immediately frozen at −20°C.
Label biotin-conjugated anti-Human IgA/streptavidin-conjugated SureLight P-3
Label protocol biotin-conjugated anti-Human IgA (Jackson ImmunoResearch, Cat. 109-065-011, West Grove, PA) / streptavidin-conjugated SureLight P-3 (Columbia Biosciences, Cat. D7-2212, Frederick, MD)
 
Hybridization protocol Milk samples were diluted 1:5 in a 1.5 mg/mL E. coli lysate solution (Antigen Discovery, Inc., Irvine, CA) in protein arraying buffer (GVS, Cat. 10485356, Sanford, ME) and incubated at room temperature for 30 min. For milk samples previously diluted in preservative solution, samples were diluted 1:2.5 in the lysate solution. Microarray slides were hydrated in arraying buffer and then probed with 250 µL of the preincubated milk samples using sealed, fitted slide chambers to avoid cross-contamination between arrays. Arrays were incubated overnight at 4°C with agitation, washed three times with Tris-buffered saline (TBS)-0.05% Tween 20 (Thermo Scientific, J77500K8, diluted 20x in molecular grade water), and incubated with Cy3-conjugated anti-human IgG diluted 1:200 in arraying buffer and biotin-conjugated anti-Human IgA diluted 1:1000 (Jackson ImmunoResearch, Cat. 709-165-098 and Cat. 109-065-011, West Grove, PA). Arrays were washed three times with TBS–0.05% Tween 20 and incubated with streptavidin-conjugated SureLight P-3 (Columbia Biosciences, Cat. D7-2212, Frederick, MD) at room temperature, protected from light. Arrays were washed 3x with TBS–0.05% Tween 20, 3x with TBS, and once with water and then air dried by being centrifuged at 1,000 x g for 4 min and left overnight in a desiccator before scanning.
Scan protocol Probed microarrays were scanned using a GenePix 4300A high-resolution microarray scanner (Molecular Devices, Sunnyvale, CA), and an image file (.tiff) was saved for each array using GenePix pro 7 software. The signals in the scanned images were quantified using Mapix software (Innopsys).
Data processing All further data processing was performed in R (http://www.R-project.org). Data were normalized by first transforming raw values using the base 2 logarithm. Next, the data set was normalized to remove systematic effects by subtracting the median signal intensity of the IVTT control spots from the IVTT antigen spots for each sample. Since the IVTT control spots carry not only the chip, sample, and batch-level systematic effects, but also antibody background reactivity to the E. coli cell-free IVTT system, this procedure normalizes the data and provides a relative measure of the specific antibody binding versus the nonspecific antibody binding to the IVTT controls. With the normalized data, a value of 0.0 means that the intensity is no different than that of the IVTT controls, a value of 1.0 indicates a doubling (2-fold) with respect to IVTT control spots, a value of 2.0 indicates 4-fold, 3.0 indicates 8-fold, etc. The normalized signal intensity of the purified protein spots is represented as the base 2 logarithm of the raw signal intensities.
 
Submission date Dec 27, 2020
Last update date Dec 28, 2020
Contact name Joseph John Campo
Organization name Antigen Discovery, Inc.
Street address 1 Technology Dr., STE E309
City Irvine
State/province CA
ZIP/Postal code 92618
Country USA
 
Platform ID GPL29530
Series (2)
GSE163901 Multipathogen analysis of IgA and IgG antigen specificity for selected pathogens in milk produced by women from diverse geographical regions: The INSPIRE Study [IgA]
GSE163903 Multipathogen analysis of IgA and IgG antigen specificity for selected pathogens in milk produced by women from diverse geographical regions: The INSPIRE Study

Data table header descriptions
ID_REF
VALUE Normalized signal intensity

Data table
ID_REF VALUE
CHIKV4263-6k.588 -0.308761472
CHIKV4263-E3.589 -0.172685436
CHIKV4263-Capsid.590 -0.233264645
CHIKV4263-E2.591 -0.397130055
CHIKV4263-E1.592 -0.7225922
CHIKV4263-Nsp3.601 -0.01526539
CHIKV4263-Nsp1.602 -0.06925861
CHIKV4263-Nsp4.603 -0.086541529
CHIKV4263-Nsp2.604 -0.075407341
D1-Hawaii-VR1254-NS4a.507 -0.148500145
D1-Hawaii-VR1254-NS2B.508 -0.14095747
D1-Hawaii-VR1254-E_truncated.509 -0.210530247
D2-New Guinea C-NS4A.510 -0.149580897
D2-New Guinea C-NS2B.511 -0.226862818
D2-New Guinea C-E.512 0.069471522
D4-H241-NS2B.761 -0.213013566
D4-H241-E.762 -0.301776209
D3-H87-3-NS4a.1021 -0.538334908
D3-H87-3-NS2B.1022 -0.570975164
D3-H87-3-E.1023 -0.455007969

Total number of rows: 912

Table truncated, full table size 30 Kbytes.




Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap